Summary table and guide for readings

Please download this document and respond to the guiding questions as you read through the papers below

Pre-reading

Spoerri L, Beaumont KA, Anfosso A, Haass NK* (in press). Real-time cell cycle imaging in a 3D cell culture model of melanoma. Methods Mol Biol accepted for publication April 2nd 2016 

Haass NK* (2015) Dynamic tumor heterogeneity in melanoma therapy: how do we address this in a novel model system?Melanoma Manag 2: 93-95http://www.futuremedicine.com/doi/pdf/10.2217/mmt.15.1

Beaumont KA, Hill DS, Daignault SM, Lui GY, Sharp DM, Gabrielli B, Weninger W, Haass NK* (2016) Cell Cycle Phase-Specific Drug Resistance as an Escape Mechanism of Melanoma Cells. J Invest Dermatol 136: 1479-1489 

Beaumont KA, Anfosso A, Ahmed F, Weninger W, Haass NK (2015). Imaging- and Flow Cytometry-based Analysis of Cell Position and the Cell Cycle in 3D Melanoma Spheroids. J Vis Exp 106: e53486

Haass NK*, Beaumont KA, Hill DS, Anfosso A, Mrass P, Munoz MA, Kinjyo I, Weninger W (2014). Real-time cell cycle imaging during melanoma growth, invasion, and drug response. Pigment Cell Melanoma Res 27: 764-776  

Beaumont KA, Mohana-Kumaran N, Haass NK* (2014; Epub 2013 Dec 23). Modeling Melanoma In Vitro and In Vivo.Special Issue "Melanoma and Neoplasms of Skin". Healthcare (Basel) 2: 27-46

Extension papers

Tonnessen CA, Haass NK* (2015) Melanoma: From tumor specific mutations to a new molecular taxonomy and innovative therapeutics.  In: Bieber T & Nestle F (Eds.): Personalized Treatment Options in Dermatology. Springer-Verlag Berlin Heidelberg, pp. 7-27, DOI: 10.1007/978-3-662-45840-2_2  (pdf link here)

Haass NK, Sproesser K, Nguyen TK, Contractor R, Medina CA, Nathanson KL, Herlyn M, Smalley KS (2008). The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxelClin Cancer Res 14: 230-239

 SPARQ-ed powerpoint template

Download template